|
gptkbp:instanceOf
|
gptkb:drug
anti-inflammatory agent
|
|
gptkbp:ATCCode
|
R03DX03
|
|
gptkbp:brand
|
Erespal
Pneumorel
|
|
gptkbp:CASNumber
|
5053-06-5
|
|
gptkbp:chemicalFormula
|
C15H20N2O2
|
|
gptkbp:countryWithdrawing
|
gptkb:European_Union
gptkb:France
gptkb:Poland
gptkb:Russia
gptkb:Ukraine
|
|
gptkbp:discoveredBy
|
gptkb:Servier
|
|
gptkbp:drugClass
|
respiratory system agent
|
|
https://www.w3.org/2000/01/rdf-schema#label
|
Fenspiride
|
|
gptkbp:legalStatus
|
prescription only (in some countries)
withdrawn in European Union
|
|
gptkbp:mechanismOfAction
|
anti-inflammatory
antihistaminic
anti-bronchoconstrictor
|
|
gptkbp:molecularWeight
|
260.33 g/mol
|
|
gptkbp:pregnancyCategory
|
not recommended
|
|
gptkbp:PubChem_CID
|
3336
|
|
gptkbp:retired
|
risk of serious heart rhythm disorders
|
|
gptkbp:routeOfAdministration
|
oral
|
|
gptkbp:sideEffect
|
gptkb:arrhythmia
nausea
QT prolongation
allergic reactions
|
|
gptkbp:usedFor
|
treatment of asthma
treatment of respiratory diseases
treatment of bronchitis
treatment of rhinopharyngitis
|
|
gptkbp:withdrawn
|
2019
|
|
gptkbp:bfsParent
|
gptkb:Servier
gptkb:Servier_Pharmaceuticals
|
|
gptkbp:bfsLayer
|
7
|